News 2023/11/06 Abionic and Lascco partner with Fapon for sepsis diagnosis in China Biopôle companies Abionic and Lascco team up with Fapon to harness a groundbreaking biomarker for sepsis detection, enhancing early diagnosis cap...
News 2024/03/26 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 2023/11/03 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
最新 2023/11/09 瑞士Abionic和Lascco公司与菲鹏生物合作,助力中国医生诊断脓毒症 位于洛桑Biopôle生命科学园区的Abionic和Lascco公司,与中国菲鹏生物合作,利用突破性的生物标志物进行脓毒症检测,增强早期诊断能力。
Spotlight 2023/06/15 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
News 2023/01/26 Bionomous secures USD 2.7 million to automate life science research Bionomous, a start-up based in the canton of Fribourg, raised USD 2.7 Million for its first CE-marked device which helps automate life science re...
Actualités 2022/10/26 Le fabricant chinois de vaccins CanSino Biologics s’installe à Genève pour lancer son vaccin Covid inhalé Ce premier vaccin Covid inhalé a été approuvé par les autorités chinoises il y a un mois. Cette technologie a également le potentiel de protéger ...
News 2023/05/26 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 2022/10/26 Chinese vaccine manufacturer CanSino Biologics sets up shop in Geneva to launch its inhaled Covid vaccine This first inhaled Covid vaccine against was approved by Chinese authorities a month ago. This technology has the potential to protect against ot...
Report 2021/08/27 スイスの循環型経済 現在の直線型経済モデルは「take-make-waste」の原則に支配されています。その結果、生態系や天然資源への圧力が増しています。直線型経済モデルは、資源不足や資源の浪費を生み、最後には気候変動や生物多様性損失などの環境危機が生じます。人類は地球の限界(プラネタリー・バウンダリー)を超...
Report 2021/07/21 Key Swiss Circular Economy Features In our current linear economic model the principle of "take-make-waste" dominates. This economic model leads to resource scarcity, waste and ulti...
News 2021/01/04 Zifo RnD Solutions coming to Basel Zifo RnD Solutions, a global provider of IT solutions for research-based organizations, opens its latest subsidiary in Basel. With Zifo Switzerla...
Aktuell 2021/01/04 Zifo RnD Solutions kommt nach Basel Zifo RnD Solutions, ein globaler Anbieter von IT-Lösungen für forschende Organisationen, eröffnet in Basel seine neueste Niederlassung. Mit Zifo ...
Success stories 2019/05/11 Roivant Sciences: Reinventing what a large pharma company of the future might look like Roivant Sciences Roivant Sciences was founded in New York by a young investor and entrepreneur, Vivek Ramaswamy. In 2016, the company opened its global headquarte...
Success stories 2020/12/11 Roivant Sciences: Sieht so das grosse Pharmaunternehmen der Zukunft aus? Roivant Sciences Roivant Sciences wurde von dem jungen Investor und Unternehmer Vivek Ramaswamy in New York gegründet. 2016 eröffnete das Unternehmen sein globale...